ACO2 and prostate cancer: Furthermore, the suppression of SIRT3 expression has been shown to enhance mitochondrial aconitase 2 (ACO2) activity, thereby facilitating mitochondrial citrate synthesis and contributing to the progression of prostate cancer 58.